Skip to main content
    G

    Gossamer Bio Inc (GOSS)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $10.98
    +0.01 (+0.09%)

    Market Cap: $67.10M

    Last updated: Nov 17, 2026 at 11:05 AM ET

    Earnings

    Performance (10Y)

    Beat Rate
    32%(10/31)
    Avg Surprise
    -7.10%
    Streak
    1 Q

    Upcoming Estimates

    Reports Mar 15, 2027 (est.)Period ending Dec 31, 2026
    EPS Consensus-$3.23
    Range-$6.13 - -$1.60
    9 analysts
    Revenue Consensus
    $3.59M
    RangeN/A
    9 analysts
    Reports May 17, 2027 (est.)Period ending Mar 31, 2027
    EPS Consensus-$6.39
    Range-$7.20 - -$5.60
    3 analysts
    EPS Revisions
    1
    0
    30d
    EPS Estimate DriftChange to current
    90d ago-$5.07-26.1%
    60d ago-$5.07-26.1%
    30d ago-$5.60-14.1%
    7d ago-$6.40+0.2%
    Current-$6.39
    Revenue Consensus
    $840.00K
    RangeN/A
    5 analysts

    Key Metrics

    Valuation
    P/E RatioN/AEV/EBITDAN/A
    Price/FCFN/AFCF YieldN/A
    Profitability
    Profit Margin-159.50%Operating Margin-136.50%
    ROE-783.00%ROIC147.40%
    Financial Health
    Debt/Equity-0.30xInterest Coverage4.82x
    Current Ratio0.60xQuick Ratio0.60x
    Trading Statistics
    Beta2.27Avg Volume175.57K
    52-Week High$309.6052-Week Low$8.29

    Technical Indicators Dashboard

    As of Nov 16, 2026, the price is 4.6% above its 50-day moving average, and the 50-day average is below the 200-day average. The 14-day RSI is 54.8, in the neutral range between 30 and 70.

    Moving Averages

    SMA 10$10.52
    SMA 20$10.19
    SMA 50$10.50
    SMA 200$30.37
    EMA 10$10.71
    EMA 20$10.43
    EMA 50$10.98
    EMA 200$41.45

    MACD

    Line: 0.20Signal: -0.01Hist: 0.21

    ADX

    ADX: 16.6+DI: 16.2-DI: 13.0

    Aroon & PSAR

    Aroon Up92.0
    Aroon Down24.0
    PSAR$7.63

    Bollinger Bands

    Upper Band$11.74
    Lower Band$8.64
    %B Position3039%(Upper)
    Band Width0.76

    RSI (14-Day)

    Neutral
    54.8

    Momentum Oscillators

    Stoch %K67.9
    Stoch %D76.7
    Williams %R-34.9
    ROC (10d)16.2%
    Momentum1.53
    CCI (20d)93.5
    MFI (14d)68.3

    Volatility Measures

    ATR (14d)$1.43(13.0%)
    StdDev (20d)0.77
    Hist Vol93.1%(High)

    Volume Flow

    VWAP$11.04
    OBV-250.8M
    AD Line4687.7B
    CMF (20d)0.140

    Volume Metrics

    Avg Vol (20d)175.3K
    Vol Ratio1.2x
    VWMA (20d)$10.23

    Pivot Points

    R3$12.18
    R2$11.79
    R1$11.38
    Pivot Point$10.99
    S1$10.58
    S2$10.19
    S3$9.78

    Advanced Oscillators

    TSI5.99
    Ultimate Osc60.4
    KST47.54

    Financial Performance

    Related GNG Research

    No research available

    Be the first to write about GOSS

    News

    GOSS Valuation

    GNG's valuation label for GOSS is Undervalued.

    P/B
    -0.6x
    All GOSS metrics

    GOSS Profitability: Margins, ROIC and FCF

    Gossamer Bio (GOSS) has a gross margin of 100.0%, an operating margin of -136.5% and a net margin of -159.5%. It posts 147.4% ROIC and a -199.0% FCF margin.

    Gross margin
    100.0%
    Operating margin
    -136.5%
    Net margin
    -159.5%
    ROIC
    147.4%
    ROE
    -783.0%
    FCF margin
    -199.0%
    GOSS financial statements

    Gossamer Bio Competitors

    The companies most similar to Gossamer Bio (GOSS) include ImageneBio, Coherus BioSciences and Genelux Corporation Common Stock.

    Sector: Healthcare

    Companies most similar to Gossamer Bio

    GOSS Analyst Ratings

    Gossamer Bio (GOSS) has a Hold consensus from 8 analysts: 4 Buy or Strong Buy, 3 Hold and 1 Sell or Strong Sell.

    Consensus
    Hold
    Analysts
    8
    Strong Buy
    1
    Buy
    3
    Hold
    3
    Sell
    0
    Strong Sell
    1
    GOSS stock forecast

    GOSS Bull Case vs Bear Case

    Bull case

    • GOSS earns a 147.4% return on invested capital.
    • GOSS grew quarterly revenue 189.1% year over year.

    Bear case

    • GOSS has a -159.5% net profit margin.

    GOSS Earnings: Beat Rate and Next Report

    Gossamer Bio (GOSS) beat the EPS estimate in 4 of the last 8 quarters (50.0%). Its next report is expected on Mar 15, 2027.

    Beat rate
    4 of 8 quarters (50.0%)
    Average surprise
    -4.5%
    EPS estimate (fiscal period ending Dec 31, 2026)
    -$3.23
    GOSS earnings history

    GOSS Earnings Date

    GOSS reports Mar 15, 2027. The date is estimated.

    GOSS Earnings Call

    The latest GOSS earnings call transcript on file is labeled 2026Q1.

    Read the 2026Q1 transcript

    See insider activity

    Updated Nov 10, 2026. Built from end-of-day prices, company filings and consensus analyst estimates. Methodology

    Frequently Asked Questions About GOSS

    When does GOSS report earnings?

    Gossamer Bio Inc (GOSS) is expected to report earnings on Mar 15, 2027.

    Does GOSS pay dividends?

    Gossamer Bio Inc (GOSS) does not currently pay a regular dividend.

    What is GOSS's market cap?

    Gossamer Bio Inc (GOSS) has a market capitalization of $67.10M with a current stock price of $10.98.

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.